Signs and Symptoms of Lupus Encephalitis
Lupus encephalitis presents most commonly as acute confusional state (ACS) with acute onset, fluctuating level of consciousness, and decreased attention, though it can also manifest as seizures, psychosis, severe cognitive dysfunction, or focal neurological deficits. 1
Clinical Presentation Framework
Common Manifestations (>5% cumulative incidence)
- Cerebrovascular disease (stroke-like symptoms)
- Seizures (generalized tonic-clonic in 67-88% or partial/complex seizures)
- Both may occur as presenting features of neuropsychiatric SLE 1
Relatively Uncommon Manifestations (1-5% cumulative incidence)
- Severe cognitive dysfunction requiring formal neuropsychological testing for confirmation
- Major depression
- Acute confusional state (ACS) - characterized by:
- Acute onset
- Fluctuating consciousness
- Decreased attention and concentration
- Often accompanied by agitation 1
- Psychosis - presenting with:
- Delusions (false beliefs refuted by objective evidence)
- Hallucinations (perceptions without external stimuli) 1
- Peripheral nervous system disorders
Rare Manifestations (<1% cumulative incidence)
- Aseptic meningitis 1
- Myelitis (transverse myelitis with rapidly evolving symptoms)
- Chorea (irregular, involuntary jerky movements)
- Cranial neuropathies
Specific Encephalitis Subtypes
Striatal Lupus Encephalitis (Rare but Severe)
Recent case reports 2, 3 describe a distinct presentation:
- Acute behavioral changes and cognitive decline
- Movement disorders including psychomotor agitation progressing to catatonia
- Stroke-like symptoms (hemiparesis, facial asymmetry)
- Bilateral symmetrical basal ganglia involvement on MRI (T2/FLAIR hyperintensities)
- May present with microinfarcts
Brainstem Encephalitis
- Altered consciousness
- Fever
- Diffusion-restricted brainstem lesions on MRI
- May mimic malignant lymphoma with elevated sIL-2R levels 4
Temporal Pattern
Critical timing consideration: 50-60% of neuropsychiatric events occur at disease onset or within the first year after SLE diagnosis, commonly (40-50%) in the presence of generalized disease activity 1
Important Diagnostic Caveats
Symptoms That Are Common But Non-Specific
The guidelines emphasize that headache, mood disorders, anxiety, and mild cognitive dysfunction are common but do not usually reflect overt CNS lupus activity 1. These should not be automatically attributed to lupus encephalitis without excluding other causes.
Mimics to Exclude
- Infections (especially in immunosuppressed patients): West Nile encephalitis can closely mimic lupus encephalitis 5
- Anti-NMDA receptor encephalitis: shares clinical features including seizures and altered mental status 6
- Corticosteroid-induced psychiatric disease: occurs in 10% of patients on prednisone ≥1 mg/kg, manifesting primarily as mood disorder (93%) rather than psychosis 1
- Metabolic disturbances and CNS infections must be systematically excluded 1
Associated Features Suggesting Lupus Encephalitis
Strong Risk Factors (≥5-fold increased risk)
- Generalized SLE activity at presentation
- Previous severe NPSLE manifestations (especially for cognitive dysfunction and seizures)
- Antiphospholipid antibodies (for cerebrovascular disease, seizures, chorea) 1
Laboratory and CSF Findings
- Mild CSF abnormalities are common (40-50%) but non-specific 1
- Elevated CSF protein (can be markedly elevated, up to 5.39 g/L in severe cases) 7
- Intrathecal IgG and IgM production in 25-66% of CNS lupus patients 8
Neuroimaging Patterns
- MRI sensitivity is 57% overall (64% in major vs 30% in minor NPSLE, 76% in focal vs 51% in diffuse NPSLE)
- Small punctate hyperintense T2-weighted focal lesions in subcortical and periventricular white matter, usually frontal-parietal regions 1
- Dural and leptomeningeal enhancement in meningitic presentations 7
Key Clinical Pitfall
The most critical error is attributing neuropsychiatric symptoms to lupus without first excluding infections, metabolic causes, and medication effects. The EULAR guidelines explicitly state that neuropsychiatric manifestations in SLE patients should be first evaluated and treated as in patients without SLE, and only secondarily attributed to SLE 1.